| 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans KB Hansen, MM Rosenkilde, FK Knop, N Wellner, TA Diep, JF Rehfeld, ... The Journal of Clinical Endocrinology & Metabolism 96 (9), E1409-E1417, 2011 | 318 | 2011 |
| Effect of an intensive lifestyle intervention on glycemic control in patients with type 2 diabetes: a randomized clinical trial MY Johansen, CS MacDonald, KB Hansen, K Karstoft, R Christensen, ... Jama 318 (7), 637-646, 2017 | 242 | 2017 |
| Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects KB Hansen, T Vilsbøll, JI Bagger, JJ Holst, FK Knop The Journal of Clinical Endocrinology & Metabolism 95 (7), 3309-3317, 2010 | 136 | 2010 |
| The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans MJ Mandøe, KB Hansen, B Hartmann, JF Rehfeld, JJ Holst, HS Hansen The American journal of clinical nutrition 102 (3), 548-555, 2015 | 72 | 2015 |
| Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes–a review KB Hansen, T Vilsbøll, FK Knop Diabetes, metabolic syndrome and obesity: targets and therapy, 155-163, 2010 | 71 | 2010 |
| Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in … KB Hansen, T Vilsbøll, JI Bagger, JJ Holst, FK Knop The Journal of Clinical Endocrinology & Metabolism 96 (2), 447-453, 2011 | 66 | 2011 |
| Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects KB Hansen, T Vilsbøll, JI Bagger, JJ Holst, FK Knop The Journal of Clinical Endocrinology & Metabolism 97 (4), 1363-1370, 2012 | 64 | 2012 |
| Treatment of type 2 diabetes with glucagon‐like peptide‐1 receptor agonists KB Hansen, FK Knop, JJ Holst, T Vilsbøll International journal of clinical practice 63 (8), 1154-1160, 2009 | 56 | 2009 |
| Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial M Ried‐Larsen, MY Johansen, CS MacDonald, KB Hansen, ... Diabetes, Obesity and Metabolism 21 (10), 2257-2266, 2019 | 52 | 2019 |
| The influence of biogeographical and evolutionary histories on morphological trait‐matching and resource specialization in mutualistic hummingbird–plant networks B Dalsgaard, PK Maruyama, J Sonne, K Hansen, TB Zanata, ... Functional Ecology 35 (5), 1120-1133, 2021 | 41 | 2021 |
| Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding L Usinger, KB Hansen, VB Kristiansen, S Larsen, JJ Holst, FK Knop Obesity surgery 21, 625-632, 2011 | 40 | 2011 |
| CropPol: A dynamic, open and global database on crop pollination A Allen‐Perkins, A Magrach, M Dainese, LA Garibaldi, D Kleijn, R Rader, ... Ecology 103 (3), e3614, 2022 | 35 | 2022 |
| Head-to-head comparison of intensive lifestyle intervention (U-TURN) versus conventional multifactorial care in patients with type 2 diabetes: protocol and rationale for an … M Ried-Larsen, R Christensen, KB Hansen, MY Johansen, M Pedersen, ... BMJ open 5 (12), e009764, 2015 | 31 | 2015 |
| Why prescribe exercise as therapy in type 2 diabetes? We have a pill for that! M Ried‐Larsen, CS MacDonald, MY Johansen, KB Hansen, ... Diabetes/metabolism research and reviews 34 (5), e2999, 2018 | 30 | 2018 |
| Effects of an intensive lifestyle intervention on the underlying mechanisms of improved glycaemic control in individuals with type 2 diabetes: a secondary analysis of a … MY Johansen, K Karstoft, CS MacDonald, KB Hansen, H Ellingsgaard, ... Diabetologia 63, 2410-2422, 2020 | 28 | 2020 |
| Dose-response effects of exercise on glucose-lowering medications for type 2 diabetes: a secondary analysis of a randomized clinical trial CS MacDonald, MY Johansen, SM Nielsen, R Christensen, KB Hansen, ... Mayo Clinic Proceedings 95 (3), 488-503, 2020 | 21 | 2020 |
| Determinants of fasting hyperglucagonemia in patients with type 2 diabetes and nondiabetic control subjects M Demant, JI Bagger, MP Suppli, A Lund, M Gyldenløve, KB Hansen, ... Metabolic Syndrome and Related Disorders 16 (10), 530-536, 2018 | 21 | 2018 |
| Once‐weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: real‐world data from a diabetes out‐patient clinic KB Hansen, M Svendstrup, A Lund, FK Knop, T Vilsbøll, H Vestergaard Diabetic Medicine 38 (10), e14655, 2021 | 20 | 2021 |
| Effects of an exercise-based lifestyle intervention on systemic markers of oxidative stress and advanced glycation endproducts in persons with type 2 diabetes: Secondary … GE Legaard, CS Feineis, MY Johansen, KB Hansen, AA Vaag, EL Larsen, ... Free Radical Biology and Medicine 188, 328-336, 2022 | 17 | 2022 |
| The interaction between metformin and physical activity on postprandial glucose and glucose kinetics: a randomised, clinical trial NS Pilmark, M Lyngbæk, L Oberholzer, I Elkjær, C Petersen-Bønding, ... Diabetologia 64, 397-409, 2021 | 17 | 2021 |
